Protein folding, misfolding, and refolding of therapeutic proteins

Biotechnology and Bioprocess Engineering

Volumn 6, Issue 4, 2001, Pages 237-243

  Shin, Hang Cheol ^a,b  

^a Soongsil University   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Amyloidosis; E. coli expression; Misfolding; Protein folding; Refolding of inclusion bodies

Indexed keywords

EID: 2142688397     PISSN: 12268372     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931984     Document Type: Article

References (63)

1. Dobson, C. M. and R. J. Ellis (1998) Protein folding and misfolding inside and outside the cell. EMBO J. 17: 5251-5254.
2. Sanger, F. (1952) The arrangement of amino acids in protein. Adv. Protein Chem. 7: 1-67.
3. Anfinsen, C. B. (1973) Principles that govern the folding of protein chains. Science 181: 223-230.
4. Levinthal, C. (1968) Are there pathways for protein folding? J. Chim. Phys. 65: 44-45.
5. Kim, P. S. and R. L. Baldwin (1990) Intermediates in the folding reactions of small proteins. Ann. Rev. Biochem. 59: 631-660.
6. Karplus, M. and D. L. Weaver (1994) Protein folding dynamics: the diffusion-collision model and experimental data. Protein Sci. 3: 650-668.
7. Wetlaufer, D. B. (1990) Nucleation in protein folding-confusion of structure and process. Trends Biochem. Sci. 15: 414-415.
8. Ptitsyn, O. B. (1995) How the molten globule became. Trends Biochem. Sci. 20: 376-379.
9. Kuwajima, K. (1989) The molten globule state as a clue for understanding the folding and cooperativity of globular-protein structure. Proteins: Struct. Funct. Genet. 6: 87-103.
10. Harrison, S. C. and R. Durbin (1985) Is there a single pathway for the folding of a polypeptide chain? Proc. Natl. Acad. Sci. USA 82: 4028-4030.
11. Huppa, J. B. and H. L. Ploegh (1998) The eS-Sence of -SH in the ER. Cell 92: 145-148.
12. Freedman, R. B., T.R. Hirst, and M.F. Tuite (1994) Protein disulfide isomerase: Building bridges in protein folding. Trends Biochem. Sci. 19: 331-336.
13. Gilbert, H. F. (1998) Protein disulfide isomerase. Methods Enzymol. 290: 26-50.
14. Lyles, M. M. and H. F. Gilbert (1991) Catalysis of the oxidative folding of ribonuclease A by protein disulfide isomerase: dependence of the rate on the composition of the redox buffer. Biochemistry 30: 613-619.
15. Creighton, T. E. (1986) Disulfide bonds as probes of protein folding pathways. Methods Enzymol. 131: 83-106.
16. Baldwin, R. L. (1989) How does protein folding get started? Trends Biochem. Sci. 163: 291-294.
17. Hantgan, R. R., G. G. Hammes, and H. A. Scheraga (1974) Pathways of folding of reduced bovine pancreatic ribonuclease. Biochemistry 13: 3421-3431.
18. Creighton, T. E. (1977) Conformational restrictions on the pathway of folding and unfolding of the pancreatic trypsin inhibitor. J. Mol. Biol. 113: 275-293.
19. Weissman, J. S. and P. S. Kim (1991) Reexamination of the folding of BPTI - predominance of native intermediates. Science 253: 1386-1393.
20. Xu, X. B., D. M. Rothwarf, and H. A. Scheraga (1996) Non-random distribution of the one-disulfide intermediates in the regeneration of ribonuclease A. Biochemistry 35: 6406-6417.
21. Volles, M. J., X. B. Xu, and H. A. Scheraga (1999) Distribution of disulfide bonds in the two-disulfide intermediates in the regeneration of bovine pancreatic ribonuclease A: Further insights into the folding process. Biochemistry 38: 7284-7293.
22. Shin, H.-C. and H. A. Scheraga (2000) Catalysis of the oxidative folding of bovine pancreatic ribonuclease A by protein disulfide isomerase. J. Mol. Biol. 300: 995-1003.
23. Shin, H.-C. and H. A. Scheraga (1999) Effect of protein disulfide isomerase on the regeneration of bovine ribonuclease A with dithiothreitol. FEBS Lett. 456: 143-145.
24. Dobson, C. M. (1999) Protein misfolding, evolution and disease. Trends Biochem Sci. 24: 329-32.
25. Sunde, M. and C. C. F. Blake (1997) The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein Chem. 50: 123-159.
26. Prusiner, S. B. (1997) Prion diseases and the BSE crisis. Science 278: 245-251.
27. Weissman, C. (1999) Molecular genetics of transmissible spongiform encephalopathies. J. Biol. Chem. 274: 3-6.
28. Jackson, G. S., I. L. Hosszu, A. Power, A. F. Hill, J. Kenney, H. Saibil, C. J. Craven, J. P. Waltho, A. R. Clarke, and J. Collinge (1999) Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 283: 1935-1937.
29. Kelly, J. W. (1998) The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8: 101-106.
30. Hartley, D. L. and J. F. Kane (1988) Properties of inclusion bodies from recombinant Escherichia coli. Biochem. Soc. Trans. 16: 101-102.
31. Marston, F. A. (1986) The purification of eukaryotic polypeptides synthesized in Escherichia coli. Biochem. J. 240: 1-12.
32. Kane, J. F. and D. L. Hartley (1991) Properties of recombinant protein-containing inclusion bodies in Escherichia coli. Bioprocess Technol. 12: 121-145.
33. Schein, C. (1990) Solubility as a function of protein structure and solvent components. Bio/Technol. 8: 308-317.
34. Rudolph, R. and H. Lilie (1996) In vitro folding of inclusion body proteins. FASEB J. 10: 49-56.
35. Fischer, B., I. Sumner, and P. Goodenough (1993) Isolation and renaturation of bio-active proteins expressed in Escherichia coli as inclusion bodies. Biotechnol. Bioeng. 41: 3-13.
36. Lilie, H., E. Schwarz, and R. Rudolph (1998) Advances in refolding of proteins produced in E. coli. Curr. Opin. Biotechnol. 9: 497-501.
37. Wetlaufer, D. B., P. A. Branca, and G.-X. Chen (1987) The oxidative folding of proteins by disulfide plus thiol does not correlate with redox potential. Protein Eng. 2: 141-146.
38. Rudolph, R. (1990) In: H. Tschesche (ed.). Modern Methods in Protein and Nucleic Acid Research. pp. 149-172, Walter de Gruyter, NY, USA.
39. Hofmann, A., M. Tai, W. Wong, and C. G. Glabe (1995) A sparse matrix screen to establish initial conditions for protein renaturation. Anal. Biochem. 230: 8-15.
40. Brinkmann, U., J. Buchner, and I. Pastan (1992) Independent domain folding of Pseudomonas exotoxin and single-chain immunotoxins: influence of interdomain connections. Proc. Natl. Acad. Sci. USA 89: 3075-3079.
41. Buchner, J. and R. Rudolph (1991) Renaturation, purification and characterization of recombinant Fab-fragments produced in Escherichia coli. Bio/Technol. 9: 157-162.
42. Cleland, J. L., C. Hedgepeth, and D. I. C. Wang (1992) Polyethylene glycol enhanced refolding of bovine carbonic anhydrase B. Reaction stoichiometry and refolding model. J. Biol. Chem. 267: 13327-13334.
43. Cleland, J. L., S. E. Builder, J. R. Swartz, M. Winkler, J. Y. Chang, and D. I. C. Wang (1992) Polyethylene glycol enhanced protein refolding. Bio/Technol. 10: 1013-1019.
44. Tandon, S. and P. M. Horwitz (1987) Detergent-assisted refolding of guanidinium chloride-denatured rhodanese. The effects of the concentration and type of detergent. J. Biol. Chem. 262: 4486-4491.
45. Smith, D. B. and K. S. Johnson (1988) Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67: 31-40.
46. Lavallie, E., E. A. DiBlasio, S. Kovacic, K. L. Grant, P. F. Schendel, and J. M. McCoy (1993) A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. R. Bio/Technol. 11: 187-193.
47. Shin, N.-K., D.-Y. Kim, C.-S. Shin, M.-S. Hong, J. Lee, and H.-C. Shin (1998) High level production of recombinant human growth hormone in Escherichia coli by a simple recombinant process. J. Biotechnol. 62: 143-151.
48. Zhang, Y., D. R. Olsen, K. B. Nguyen, P. S. Olson, E. T. Rhodes, and D. Mascarenhas (1998) Expression of eukaryotic proteins in soluble form in Escherichia coli. Protein Expr. Purif. 12: 159-165.
49. Forrer, P. and R. Jaussi (1998) High-level expression of soluble heterologous proteins in the cytoplasm of Escherichia coli by fusion to the bacteriophage lambda head protein D. Gene 224: 45-52.
50. Meyer, D. E. and A. Chilkoti (1999) Purification of recombinant proteins by fusion with thermally-responsive polypeptides. Nature Biotechnol. 17: 1112-1115.
51. Nilsson, B., E. Holmgren, S. Josephson, S. Gatenbeck, L. Philipson, and M. Uhlen (1985) Efficient secretion and purification of human insulin-like growth factor I with a gene fusion vector in Staphylococci. Nucleic Acids Res. 13: 1151-1162.
52. Bedouelle, H. and P. Duplay (1988) Production in Escherichia coli and one-step purification of bifunctional hybrid proteins which bind maltose. Export of the Klenow polymerase into the periplasmic space. Eur. J. Biochem. 171: 541-549.
53. Jeong, K. J. and S. Y. Lee (2000) Secretory production of human leptin in Escherichia coli. Biotechnol. Bioeng. 67: 398-407.
54. Baneyx, F. (1999) Recombinant protein expression in Escherichia coli. Curr. Opin. Biotechnol. 10: 411-421.
55. Thomas, P. J., B.-H. Qu, and P. L. Pedersen (1995) Defective protein folding as a basis of human disease. Trends Bichem. Sci. 20: 456-459.
56. Sarmientos, P., M. Duchesne, P. Denefle, J. Boiziau, N. Fromage, N. Delporte, F. Parker, Y. Lelievre, J.-F. Mayaux, and T. Cartwright (1989) Synthesis and purification of active human tissue plasminogen activator from Escherichia coli. Bio/Technol. 7: 495-501.
57. Kohnert, U., R. Rudolph, J. H. Verheijen, E. J. D. Weening-Verhoeff, A. Stern, U. Opitz, U. Martin, H. Lill, H. Printz, M. Lechner, G.-B. Kresse, P. Buckel, and S. Fischer (1992) Biochemical properties of the kringle 2 and protease domains are maintained in the refolded t-PA deletion variant BM 06.022. Protein Eng. 5: 93-100.
58. Yamanishi, K., M. Takahashi, T. Nishida, Y. Ohtomo, M. Takano, S. Nakai, and Y. Hirai (1991) Renaturation, purification, and characterization of human truncated macrophage colony-stimulating factor expressed in Escherichia coli. J. Biochem. 109: 404-409.
59. Tsuji, T., R. Nakagawa, N. Sugimoto, and K. Fukuhara (1987) Characterization of disulfide bonds in recombinant proteins: Reduced human interleukin 2 in inclusion bodies and its oxidative refolding. Biochemistry 26: 3129-3134.
60. van Kimmenade, A, M. W. Bond, J. H. Schumacher, C. Laquoi, and R. A. Kastelein (1988) Expression, renaturation and purification of recombinant human interleukin-4 from Escherichia coli. Eur. J. Biochem. 173: 109-114.
61. Ejima, D., M. Watanabe, Y. Sato, M. Date, N. Yamada, and Y. Takahara (1999) High yield refolding and purification process for recombinant human interleukin-6 expressed in Escherichia coli. Biotechnol. Bioeng. 62: 301-310.
62. Hodges, D. J., D. G. Reid, A. D. Rowan, I. M. Clark, and T. E. Cawston (1998) Preparation of recombinant tissue inhibitor of metalloproteinases-1 (TIMP-1) in high yield and identification of a hydrophobic surface feature. Eur. J. Biochem. 257: 562-569.
63. Williamson, R. A., D. Natalia, C. K. Gee, G. Murphy, M. D. Carr, and R. B. Freedman (1996) Chemically and conformationally authentic active domain of human tissue inhibitor of metalloproteinases-2 refolded from bacterial inclusion bodies. Eur. J. Biochem. 241: 476-483.